• Users Online: 177
  • Print this page
  • Email this page


 
 
Table of Contents
ORIGINAL ARTICLE
Year : 2016  |  Volume : 3  |  Issue : 2  |  Page : 31-35

Pre-blood-donation screening of volunteer prisoners for hepatitis B and C in prisons of the Punjab, Pakistan


1 Department of Microbiology and Molecular Genetics, University of the Punjab, Lahore-54600, Pakistan
2 Department of Human Genetics and Molecular Biology, University of Health Sciences, Lahore-54600, Pakistan
3 Department of Human Genetics and Molecular Biology, University of Health Sciences; Sundas Foundation Molecular Analysis Centre, Lahore - 54660, Pakistan
4 University of Management and Technology, Lahore - 54600, Pakistan

Date of Web Publication6-Jul-2017

Correspondence Address:
Muhammad Aslamkhan
Department of Human Genetics & Molecular Biology, University of Health Sciences, Lahore-54600
Pakistan
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.5530/ami.2016.2.8

Rights and Permissions
  Abstract 


Objectives: To identify the potential benefits of pre-donation screening of blood.
Study design: Retrospective.
Place and Duration: Prisons in the Punjab province. From January 2011 t0 September 2013.
Background: Prisoners, as a high risk group, are not recommended for blood donations. In Pakistan, however, prisoners are legally allowed to donate blood and get thirty days remission.
Methodology: Volunteer prisoners, after examination and verification by a physician for their physical fitness, were tested for Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) by Rapid Test Kit before bleeding. Data was analyzed by Epi-Info.
Results: A total of 5894 male volunteer prisoner donors were screened and 1038 (17.6%) were rejected because of hepatitis infection. The mean age was 28 years (range; 17 - 70 years). Of 5894 prisoners, 857 (14.5%) were HCV positive and 222 (3.8%) were HBV positive. Co-infection of HCV and HBV was present among 41 (0.7%). Hepatitis infection, among convicted- prisoner blood donor, is significantly associated with higher seroprevalence for HCV (OR 1.35, 95% C.I. 1.17-1.57) while under-trial- prisoner is significantly associated with higher seroprevalence for HBV (OR 1.40, 95% C.I. 1.06-1.85).
Conclusion: Hepatitis B and C viruses were responsible for almost 18% prisoner blood donor rejection. Pre-donation screening of blood donors is an effective intervention to improve the safety and limit the cost of blood. Treatment of identified infected prisoners may contribute to public health. In the international scenario this study findings necessitate the amendments in the relevant prison rules.

Keywords: Hepatitis, HBV, HCV, Jail, Pre-donation screening, prisoner blood donors, Punjab, Pakistan


How to cite this article:
Qadeer MI, Aslamkhan M, Akhtar MS, Ellahi F. Pre-blood-donation screening of volunteer prisoners for hepatitis B and C in prisons of the Punjab, Pakistan. Acta Med Int 2016;3:31-5

How to cite this URL:
Qadeer MI, Aslamkhan M, Akhtar MS, Ellahi F. Pre-blood-donation screening of volunteer prisoners for hepatitis B and C in prisons of the Punjab, Pakistan. Acta Med Int [serial online] 2016 [cited 2021 Sep 17];3:31-5. Available from: https://www.actamedicainternational.com/text.asp?2016/3/2/31/209793






  Introduction Top


Donated blood plays a pivotal role for saving lives of thalassemic, hemophilic, severely anemic, hepatitis patients, and during acute emergencies subject to the condition that the blood is safe and free from pathogens; because infected blood will be injurious to the Health of recipients. The screening of prospective donors is vital to ensure the delivery of safe blood to the public.[1] The prevalence of various STDs (sexually transmitted diseases) among routinely accepted blood donors is well documented.[2],[3],[4] Blood borne pathogens are efficiently transmitted by percutaneous (e.g., needle- stick, shaving blades, etc.) exposure to infectious blood and transfusion of blood and blood products. HBV (Hepatitis B Virus), HCV (Hepatitis C Virus) and Syphilis are also transmitted per mucosal body fluids (e.g., semen, vaginal fluid, etc.).[5]

In the absence of epidemiologic studies in Pakistan, the prevalence of HBV infection is estimated to be 2.5% and that of HCV infection as 4.8%. It is one of the highest rates in the world.[6] However, Blood donor studies in Pakistan, showed various prevalence of HCV ranging from 0.82% to 6.21%.[7],[8],[9],[10],[11],[12],[13],[14],[15],[16] Similarly most of the studies, based on screening of donors at blood banks in Pakistan, gave prevalence rate of, HBV as less than 3.54%.[7],[9],[10],[11],[12],[13],[17],[18],[19]

The high transmissionof blood-borne viruses i.e., HBV, and HCV in prisons is well known for several years.[20],[21],[22] Prisoners are disproportionately affected by these infections, with prevalence of two to ten times higher than in the general population.[23] Prisoners have high risk behaviors including unsafe sexual practices, sharing shaving blades and syringes. In prisons MSM practice exists especially in juvenile and drug addict barracks. Young age and first time offenders are forced for sexual favour by elders and more aggressive inmates. Overcrowding in these barracks also fuels the high risk sexual behaviors among them.[24]

Prisoners, being very high-risk group for blood-borne infections, are not recommended for blood-donation globally. However, in Pakistan, not much published data on prisoner blood donors is available. Prisoners are allowed to donate blood, vide Pakistan Prison Act 1978, Rule No. 212, subject to their medical fitness and thirty days extra remission is awarded. Medical fitness is declared by Prison Medical Officer. Six months interval is mandatory between each donation. A prisoner can donate blood many times with his will but he can earn maximum four remissions.

According to Pakistan Prisons Remission System, prisoners can earn other remission besides blood donation. Under Pakistan Prison Act, rule 217, a prisoner cannot earn ordinary remission more than one-third of his conviction and Superintendent Prison can forfeiture ordinary remission of any prisoner subject to his poor conduct. However, remission awarded against Blood donation is not liable to forfeiture like ordinary remission and is also exclusive of the maximum limit of one third remissions. So prisoners donate blood voluntarily to get early release. However, under trial prisoners may also donate blood voluntarily on humanitarian grounds. Under trial prisoners can also get blood donation remission if their period passed in jail as under-trial is included in conviction by the Law-Court. Practice of blood donation by prisoners to NGOs (Non-Governmental Organizations) for thalassemic or other patients, who need blood transfusion, are quite common in the Punjab Prisons. To collect blood donation from prisoners is easy as compared to general population, because motivated donors are available in large number at one place: added incentive is remission. NGOs, which want to collect blood from Prisoners, seek permission from the Inspector General (IG) Prison. Generally permission is granted subject to screening of Prisoners, inside Jail premises, before donating blood against HIV, AIDS H BV and syphilis, and Physical fitness of the volunteer by the Medical Officer Jail. During blood camp prisoners (willing to donate blood) are screened by Rapid test kit.

Thus, the present study was conducted to find out the seroprevalence of Hepatitis B and C among prison inmates who volunteered blood donors from prisons of the Punjab.


  Methodologies Top


This retrospective study was conducted from January, 2011 to September 2013, in the prisons of the Punjab. The permission was sought by Sundus Foundation, a NGO, with qualified staff and well equipped laboratory, which aims to identify, register and provide blood transfusion supportive therapy to persons afflicted with haemophilia and thalassemia. Blood for transfusion to these persons is collected from willing donors for which blood donation camps are organized in colleges, universities, factories, markets as well as in prisons round the year. To ensure the safety of blood, donors are checked, before bleeding, by a physician not only for physical fitness but also for HCV and HBV, which is done by rapid test kit.

Data regarding, age, cause of confinement, type of prisoner and prison of confinement were collected for each volunteer prisoner blood donor, including their consent. The protocol was approved by the Institutional Ethical Committee (IEC). The Epi-Info version 3.5.1 was used for data entry and analyses while figures were made using Microsoft Office. The frequency data were compared by chi-square test. Odd ratios (OR) were calculated by using univariate analyses. A p value less than 0.05 (2-tailed) was considered statistically significant.


  Results Top


A total of 5894 intended volunteer prisoner blood donors were screened out of which 1038 (17.6%) were denied due to hepatitis infection. All were male and 65% of them were between the ages of 21 to 30 years. Of 5894 jail inmates, 2219 (37.6%) were convicted prisoners (mean age 29 years) and 3675 (62.4%) under trial prisoners (mean age 27 years). 857 (14.5%) were HCV positive and 222 (3.8%) were HBV positive. Dual infection with HBV and HCV was 0.7%. Of 2219 convicted prisoner donors, 366 (16.5%) were HCV positive and 81 (3.7%) were HBV positive. Of 3675 under trial prisoner donors, 491 (13.4%) were HCV positive and 141 (3.8%) were HBV positive.

Analyses on regional basis between Northern Region and Central Region of the Punjab prison revealed higher incidence of both HCV and HCB in the Central Region. Region wise prevalence of HCV and HBV is shown in [Figure 1].
Figure 1: Region wise prevalence of HCV and HBV among volunteer prisoners donors in the punjab prisons

Click here to view


Age wise distribution of intended prisoner donors and prevalence of HCV and HBV is presented in [Table 1] and [Figure 2.1], [Figure 2.2], [Figure 2.3]. The temporal trend and year wise distribution of HCV and HBV is shown in [Table 2]. and [Figure 3.1], [Figure 3.2], [Figure 3.3].
Table 1: Age wise prevalence of HCV and HBV among volunteer prisoner donors

Click here to view


Click here to view
Table 2: Year wise prevalence of HCV and HBV among volunteer prisoners donors in the Punjab prisons

Click here to view


Click here to view


Being convicted prisoner blood donor is significantly associated with higher sero prevalence for HCV (OR 1.35, 95% C.I. 1.17-1.57, p< 0.05) and being under trial prisoner is significantly associated with higher sero prevalence for HBV (OR 1.40, 95% C.I. 1.06-1.85, p< 0.05).


  Discussion Top


High Prevalence of these infections as compared to general population blood donors indicates that prisoners are high risk group. Prisoner blood donation is prohibited worldwide even for research purposes. So the studies regarding prevalence of these infections among prisoner blood donors are scarce.

This study is believed to be the first of its kind in the country. High HCV prevalence simulates with an 'outbreak' like situation of HCV within prison settings of Punjab province. The prevalence of HCV among intended healthy prisoner blood donors is three times high and HBV 1% high as compared to general population in Pakistan.[7] This study supports previous reports that prisoners represent a high- risk group for blood borne diseases and prevalence of HCV and HBV is many times higher than general population.[25],[26],[27],[28],[29],[30],[31]

The prevalence of HCV is 14.54% and HBV 3.8% in this study. In the medical and public health literature review over a 13-year period (January 1994–September 2007) prevalence of HCV was found 3% and HBV 2.4% among healthy adult blood donors in Pakistan.[32] Another study revealed prevalence of HCV Infection 2.4% among replacement blood donors and 1% among voluntary blood donors in Pakistan.[33] Another study shows prevalence 4.85%.[34] At services hospital Lahore it was found 4.97% among healthy blood donors.[15],[35] In railway hospital Rawalpindi prevalence of HCV was 6.2% and HBV1.8% but in CMH Sialkot prevalence of HCV among volunteer blood donors was 6.52%.[36] In a study conducted in Shaukat Khanum Cancer Hospital including volunteer and replacement blood donors found HCV and HBV prevalence 3.68% and 2.22% respectively. This study includes blood donation of ten years.[37] The data published with respect to prevalence of HBs Ag among the blood donors of Pakistan since the year 2005 to date indicates that the average prevalence of HBs Ag was 3.02% in Punjab.[38]

The prevalence of HCV and HBV are showing regional trend. Prevalence of HCV and HBV are high among intended prisoner blood donors of Central Region as compared to Northern Region. Almost no increasing or decreasing temporal trend in the prevalence of HCV and HBV is seen during three consecutive years.


  Conclusions Top


The study has shown clearly that prevalence of HCV among intended prisoner blood donors is 2-5 times high and HBV 1.4 -2% high as compared to general population volunteer blood donors. This is underling reason of not recommending prisoners for blood donation. The probability of infection from an exposure varies in proportion to the prevalence of the virus in the population. Among the population with high prevalence of HCV and HBV the risk of missing the detection of antibodies against these viruses during window period is high.

It is evident from this interventional study that pre-donation screening of blood substantially minimizes the risk of collection of infected blood for donation.

On the finding of this study, Sundus Foundation has stopped blood collection from prisoners.

One the other hand it also identifies the disease burden which facilitates evidence based policy making for prevention and control of these infections in this population. Prison period is an ideal time for treatment of positive cases and to educate those who are on risk.


  Acknowledgements Top


This work has been supported by the research initiative of University of Health Sciences Lahore, Pakistan.



 
  References Top

1.
Ministry of Health, Jamaica. National Transfusion Service. Ministry of Health, Kingston Jamaica. 1999.  Back to cited text no. 1
    
2.
Ministry of Health, Jamaica. Surveillance report 1999, 2000 and 2001. Ministry of Health, Kingston, Jamaica.  Back to cited text no. 2
    
3.
Brady-West DC, Buchner LM. Retrospective audit of blood donation at a hospital-based blood centre, Implications for blood product supply and safety. West Indian Med J 2000; 49: 226–8.  Back to cited text no. 3
    
4.
Ampofo W, Nii-Trebi N, Ansah J, Abe K, Naito H, Aidoo S, et al. Prevalence of blood-borne infectious diseases in blood donors in Ghana. J ClinMicrobiolol 2002; 40: 3523–5.  Back to cited text no. 4
    
5.
Cindy MW, Keith MS, Scott SS. Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS 2005;19 (3):S41–S46.  Back to cited text no. 5
    
6.
Qureshi H, Bile KM, Jooma R, Alam SE, Afridi HUR. Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East Mediterr Health J 2010; 16: S15–23.  Back to cited text no. 6
    
7.
Mumtaz S, Rehman MU, Muzaffar M, Hassan MU, Iqbal W. Frequency of seropositive blood donors for hepatitis B, C and HIV viruses in railway hospital. Rawalpindi.Pakistan J Med Res 2002; 41: 51–3.  Back to cited text no. 7
    
8.
Ryas M, Hussain T, Bhatti FA, Ahmed F, Tariq WZ, Khattak MF. Epidemiology of Hepatitis C Virus Infection in Blood Donors in Northern Pakistan.J Rawal Med Coll 2001; 5: 56–9.  Back to cited text no. 8
    
9.
Asif N, Khokhar N, Ilahi F. Sero-prevalence of HBV, HCV and HIV infection among voluntary non remunerated and replacement donors Northern Pakistan.Pak J Med Sci 2004; 20: 24–8.  Back to cited text no. 9
    
10.
Mujeeb A, Aamir K, Mehmood K. Sero-prevalence of HBV, HCV and HIV infections among college going first time voluntary blood donors.J Pak Med Assoc 2000; 50: 269–70.  Back to cited text no. 10
    
11.
Khattak M F, Salamat N, Bhatti F A, Qureshi T Z. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan.J Pak Med Assoc 2002; 52: 398–402.  Back to cited text no. 11
    
12.
Ali N, Khattak J, Anwar M, Tariq WUZ, Nadeem M, Irfan M, et al. Prevalence of hepatitis B surface antigen and hepatitis C antibodies in young healthy adults.Pakistan J Pathol 2002; 13(2): 3–6.  Back to cited text no. 12
    
13.
Khokhar N, Gill ML, Malik GJ. General seroprevalence of hepatitis c and hepatitis b virus infections in population.J Coll Physicians Surg Pak 2004; 14: 208–10.  Back to cited text no. 13
    
14.
Ali N, Nadeem M, Qamar A, Qureshi AH, Ejaz A. Frequency of Hepatitis C virus antibodies in blood donors in Combined Military Hospital, Quetta.Pak J Med Sci 2003; 19: 41–4.  Back to cited text no. 14
    
15.
Ahmad S, Gull J, Bano KA, Aftab M, Khokhar MS. Prevalence of Anti Hepatitis C antibodies in healthy blood donors at Services Hospital Lahore.Pakistan Postgrad Med J 2002; 13: 18–20.  Back to cited text no. 15
    
16.
Lone DS, Aman S, Aslam M. Prevalence of Hepatitis C Virus antibody in Blood Donors of Lahore.Biomedica 1999; 15:103–7.  Back to cited text no. 16
    
17.
Ahmed F, Shah SH, Tariq M, Khan JA. Prevalence of hepatitis B carrier and HIV in healthy blood donors at Ayub Teaching Hospital.Pak J Med Res 2000; 39: 91–2.  Back to cited text no. 17
    
18.
Rahman MU, Akhtar GN, Lodhi Y. Transfusion transmitted HIV and HBV infections in Punjab, Pakistan.Pak J Med Sci 2002; 18: 18–25.  Back to cited text no. 18
    
19.
Ahmed M. Hepatitis B surface Antigen study in Professional and Volunteer Blood Donors.Ann Abbasi Shaheed Hosp Karachi Med Dent Coll 2001; 6: 304–6.  Back to cited text no. 19
    
20.
Adjei AA, Armah HB, Gbagbo F, Ampofo WK, Quaye IKE, Hesse IFA, et al. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis among prison inmates and officers at Nsawam and Accra, Ghana. Medical Microbiology J 2006; 55: 593–597  Back to cited text no. 20
    
21.
Catalan-Soares BC, Almeida RTP, Carneiro-Proietti ABF. Prevalence of HIV-1/2, HTLV-I/II, hepatitis B virus (HBV), hepatitis C virus (HCV), Treponemapallidum and Trypanosomacruzi among prison inmates at Manhuacu, Minas Gerais State, Brazil. Rev Soc Bras Med Trop 2000; 33: 27–30.  Back to cited text no. 21
    
22.
Haber PS, Parsons SJ, Harper SE, White P A, Rawlinson W D, Lloyd AR. Transmission of hepatitis C within Australian prisons. Med J Aust1999; 171: 31–33.  Back to cited text no. 22
    
23.
Weinbaum CM, Sabin KM, Santibanez SS. Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS 2005;19: 41–46  Back to cited text no. 23
    
24.
Stern V. A Sin Against the Future, Imprisonment in the World: Penguin Books Ltd; 1998.  Back to cited text no. 24
    
25.
Ethan G, Mirjam CK, Laura G, Marvin M, Edward W, Al B, et al. HIV and Hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta- analysis. BMC Public Health 2010; 10:777  Back to cited text no. 25
    
26.
Centers for Disease Control and Prevention: HIV prevalence estimates -United States, 2006. JAMA 2009; 301:27–29.  Back to cited text no. 26
    
27.
Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan TP. Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis 2002, 35:305–312.  Back to cited text no. 27
    
28.
Maruschak L. HIV in Prisons., US Department of Justice, Bureau of Justice Statistics; 2008 [May 12, 2010]. Report No: NCJ-222179. Washington, DC. 2006.  Back to cited text no. 28
    
29.
Hennessey KA, Kim AA, Griffin V, Collins NT, Weinbaum CM, Sabin K. Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States. J Urban Health. 2009; 86: 93–105. doi: 10.1007/s11524-008-9305-8.  Back to cited text no. 29
    
30.
Weinbaum C, Lyerla R, Margolis HS. Prevention and control of infections with hepatitis viruses in correctional settings.Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003; 52: 1–36.  Back to cited text no. 30
    
31.
Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releases from US correctional facilities, 1997.Am J Public Health.2002; 92: 1789–1794.  Back to cited text no. 31
    
32.
Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and C in Pakistan: prevalence and risk factors. Int J Infect Dis.2009;13(1): 9–19.  Back to cited text no. 32
    
33.
Mujeeb SA, Pearce MS. Temporal trends in hepatitis B and C infection in family blood donors from interior Sindh, Pakistan. BMC Infectious Diseases2008; 8:43. doi:10.1186/1471-2334-8-43  Back to cited text no. 33
    
34.
Rehman MU, Akhtar GN, Ladhi Y. Seroprevalence of Heatitis-C antibodies in blood donors. Pak JMedSci, 2002; 18(3); 193–196.  Back to cited text no. 34
    
35.
Khan ZT, Asim S, Tariq Z, Ehsan IA, Malik RA, Ashfaq B, et al. Prevelance of transfussion transmitted infections among healthy blood donors in Rawalpindi. Int J of pathology; 2007; 5(1): 21–25  Back to cited text no. 35
    
36.
Mumtaz S, Rehman MU, Muzaffar M, Hassan MU, Iqbal W. Frequency of seropositive blood donors for hepatitis B, C and HIV viruses in railway hospital Rawalpindi. Pakistan J. Med. Research 2002;41.  Back to cited text no. 36
    
37.
Sultan F, Mehmood T, Mahmood MT. Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience. Int J Infect Dis. 2007; 11: 407–412  Back to cited text no. 37
    
38.
Khan NU, Siddique L, Ali I, Iqbal A, Munir I, Rashid F, et al. Prevalence of hepatitis B in the blood donors of N-W.F.P and FATA regions and the current scenario of HBV infection in Pakistan. African J of Biotechnology. 2010; 9(37): 6162–6166.  Back to cited text no. 38
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]
 
 
    Tables

  [Table 1], [Table 2]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
Abstract
Introduction
Methodologies
Results
Discussion
Conclusions
Acknowledgements
References
Article Figures
Article Tables

 Article Access Statistics
    Viewed1533    
    Printed87    
    Emailed0    
    PDF Downloaded104    
    Comments [Add]    

Recommend this journal